NeuroTech Talk series - Implantable Brain Interfaces

Event details
Date | 07.04.2021 |
Hour | 18:30 › 20:30 |
Speaker | Carolina Aguilar, CEO & co-Founder, INBRAIN Neuroelectronics. Thomas Oxley, MD, PhD, founder and CEO of Synchron. Matt Angle, PhD, founder and CEO of Paradromics |
Location |
via Zoom web-streaming only, due to Covid-19 pandemic
Online
|
Category | Conferences - Seminars |
In collaboration with the Center for Neuroprosthetics (CNP) at EPFL, Innovation Forum Lausanne is organizing the NeuroTech Talk series. This conference series revolves around industrial applications in the fields of neuroscience and neuroprosthetics. The goal of this project is to broaden the view of researchers on what's outside academia. Beyond the science behind these applications, the seminars will focus on the personal, entrepreneurial challenges coming with the clinical translation of advances in neurotechnology. Speakers will share their career paths, the choices that brought them where they are today and their advices for PhD students and researchers seeking a future in the medical device industry.
This session taking place on 7th April 2021 at 18:30 CET will focus on Implantable Brain Interfaces. Professor Diego Ghezzi, head of the Medtronic Chair in Neuroengineering at EPFL, will be leading the seminar and introducing the speakers:
- Carolina Aguilar, CEO & co-Founder, INBRAIN Neuroelectronics. After a career as Neuroscientist and Business Executive, she and the team now develop a high density, high resolution and graphene-based neural interface.
- Thomas Oxley, MD, PhD, founder and CEO of Synchron. He conceived, developed and is now translating into clinics the StentrodeTM, a device able to record brain activity from within a blood vessel.
- Matt Angle, PhD, founder and CEO of Paradromics. He and his team are working on a novel high data rate interface between brains and computers.
Practical information
- General public
- Free
Contact
- eleonora.borda@epfl.ch adele.fanelli@epfl.ch nicolas.fumeaux@epfl.ch